1La Marca A, MorganteG, Palumbo M, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril,2002, 78(6): 1234-1239.
2Vrbikova J, Hill M, Starka L, et al. The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polvcvstic ovary syndrome. Eur J Endocrinol, 2001, 144(6):619-628.
3Arslsnian SA, Lewy V, Danadian K, et al. Mefformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab, 2002, 87(4): 1555-1559.
4Morin-Papunen L, Vauhkonen I, Koivunen R, et al. Metformin versus ethinyl estradiol--cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab, 2003, 88(1)148-156.
5Kelly C J, Gordon D. The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol, 2002, 147(2):217-221.
6fGeorge SS, George K, Irwin C, et al. Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial. Hum Reprod, 2003, 18(2):299-304.
7Kocak M, Caliskan E, Simsir C, et al. Mefformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril,2002, 77(1):101-106.
8Vandermolen DT, Ratts VS, Evans WS, et al. Mefformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who axe resistant to clomiphene citrate alone. Fertil Steril, 2001, 75(2):310-315.
9Sturrock ND, Lannon B, Fay TN. Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br J Clin Pharmacol, 2002, 53(5):469-473.
10Yarali H, Yildiz BO, Demirol A, et al. Co-administration of mefformin during rFSH treatment in patients with elomiphene citrate-resistant polyeystie ovary syndrome: a prospective randmized trial. Hum Reprod,2002,17(2):2481-2482.
